FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

79605009: 3 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    132068015 Three en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442100016 3 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442101017 3 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33111000077115 trois fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    trois Is a General adjectival modifier false Inferred relationship Some
    trois Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False trois Inferred relationship Some 2
    Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False trois Inferred relationship Some 2
    Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False trois Inferred relationship Some 1
    Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 4.5 mg/mL solution for infusion Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 2 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Flupentixol (as flupentixol hydrochloride) 3 mg oral tablet Has presentation strength numerator value False trois Inferred relationship Some 1
    Product containing only naphazoline and polyvinyl alcohol and zinc sulfate (medicinal product) Count of base of active ingredient False trois Inferred relationship Some
    Chlorphenamine and methscopolamine and pseudoephedrine only product Count of base of active ingredient False trois Inferred relationship Some
    Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) Count of base of active ingredient False trois Inferred relationship Some
    Chlorphenamine and phenylephrine and phenyltoloxamine only product Count of base of active ingredient False trois Inferred relationship Some
    Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form Count of base of active ingredient False trois Inferred relationship Some
    Product containing only cetyl alcohol and colfosceril and tyloxapol (medicinal product) Count of base of active ingredient False trois Inferred relationship Some
    Product containing only chlorphenamine and paracetamol and phenylephrine (medicinal product) Count of base of active ingredient False trois Inferred relationship Some
    Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False trois Inferred relationship Some 1
    Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet Count of base of active ingredient False trois Inferred relationship Some
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing only aliskiren and amlodipine and hydrochlorothiazide in oral dose form (medicinal product form) Count of base of active ingredient False trois Inferred relationship Some
    Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Tobramycin 3 mg/mL eye solution Has concentration strength numerator value False trois Inferred relationship Some 1
    Product containing only amlodipine and hydrochlorothiazide and olmesartan in oral dose form (medicinal product form) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator value False trois Inferred relationship Some 1
    Product containing precisely pramipexole dihydrochloride 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False trois Inferred relationship Some 1
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely gentamicin sulfate 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False trois Inferred relationship Some 1
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Product containing only amlodipine and hydrochlorothiazide and valsartan in oral dose form (medicinal product form) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment Has concentration strength numerator value False trois Inferred relationship Some 1
    Tobramycin 3 mg/g eye ointment Has concentration strength numerator value False trois Inferred relationship Some 1
    Product containing only caffeine and isometheptene and paracetamol in oral dose form (medicinal product form) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely hydromorphone hydrochloride 3 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength numerator value False trois Inferred relationship Some 1
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension Has concentration strength numerator value False trois Inferred relationship Some 2
    Product containing only magnesium hydroxide and omeprazole and sodium bicarbonate in oral dose form (medicinal product form) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) Has presentation strength numerator value False trois Inferred relationship Some 1
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Paliperidone 3 mg prolonged-release oral tablet Has presentation strength numerator value False trois Inferred relationship Some 1
    Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely glyceryl trinitrate 3 milligram/1 each prolonged-release buccal tablet (clinical drug) Has presentation strength numerator value False trois Inferred relationship Some 1
    Adapalene 3 mg/g cutaneous gel Has concentration strength numerator value False trois Inferred relationship Some 1
    Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength numerator value False trois Inferred relationship Some 1
    Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False trois Inferred relationship Some 1
    Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule Count of base of active ingredient False trois Inferred relationship Some
    Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule Count of base of active ingredient False trois Inferred relationship Some
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Count of base of active ingredient False trois Inferred relationship Some
    Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Count of base of active ingredient False trois Inferred relationship Some
    Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule Count of base of active ingredient False trois Inferred relationship Some
    Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule Count of base of active ingredient False trois Inferred relationship Some
    Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule Count of base of active ingredient False trois Inferred relationship Some
    Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False trois Inferred relationship Some 3
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength numerator value False trois Inferred relationship Some 2
    Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False trois Inferred relationship Some 3
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution Count of base of active ingredient False trois Inferred relationship Some
    Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False trois Inferred relationship Some 1
    Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False trois Inferred relationship Some 1
    Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False trois Inferred relationship Some
    Pseudoephedrine hydrochloride 3 mg/mL oral solution Has concentration strength numerator value False trois Inferred relationship Some 1
    Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution Count of base of active ingredient False trois Inferred relationship Some
    Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream Count of base of active ingredient False trois Inferred relationship Some
    Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Count of base of active ingredient False trois Inferred relationship Some
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False trois Inferred relationship Some 1

    Start Previous Page 4 of 5 End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start